Calamos Advisors LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 45 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$9,972,500
+1.3%
10,000,0000.0%0.05%
+6.5%
Q4 2022$9,841,900
+0.7%
10,000,0000.0%0.05%
+2.2%
Q3 2022$9,776,000
+0.8%
10,000,0000.0%0.04%
+7.1%
Q2 2022$9,697,000
-0.8%
10,000,0000.0%0.04%
+13.5%
Q1 2022$9,771,000
-1.6%
10,000,0000.0%0.04%0.0%
Q4 2021$9,925,000
+0.6%
10,000,0000.0%0.04%
-14.0%
Q3 2021$9,868,000
-0.4%
10,000,0000.0%0.04%
-4.4%
Q2 2021$9,910,000
+2.6%
10,000,0000.0%0.04%
-15.1%
Q1 2021$9,658,000
+2.2%
10,000,0000.0%0.05%
-3.6%
Q4 2020$9,448,000
+2.3%
10,000,0000.0%0.06%
-6.8%
Q3 2020$9,237,000
+4.4%
10,000,0000.0%0.06%
-6.3%
Q2 2020$8,846,000
+8.8%
10,000,0000.0%0.06%
-1.6%
Q1 2020$8,133,000
-31.1%
10,000,000
-23.1%
0.06%
+10.3%
Q4 2019$11,809,000
-43.1%
13,008,000
-41.7%
0.06%
-48.7%
Q3 2019$20,750,000
-4.9%
22,303,0000.0%0.11%
-6.6%
Q2 2019$21,829,00022,303,0000.12%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opti Capital Management, LP 37,347,000$36,345,0004.44%
CAMDEN ASSET MANAGEMENT L P /CA 51,663,000$49,804,0002.44%
Wellesley Asset Management 19,638$19,107,0002.29%
Radcliffe Capital Management, L.P. 58,877,000$56,759,0002.26%
DeepCurrents Investment Group LLC 29,151,000$28,254,0000.97%
Penn Mutual Asset Management, LLC 675,000$651,0000.74%
SHENKMAN CAPITAL MANAGEMENT INC 6,212,000$6,056,0000.71%
Sonora Investment Management, LLC 5,775,000$5,568,0000.44%
OAKTREE CAPITAL MANAGEMENT LP 22,802,000$22,095,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 23,405,000$22,701,0000.19%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders